Rakhi Kumar
CIK: 0001856296
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Jun 19, 2026NPCE
NeuroPace Inc
Award(A)Direct989 shares at avg. $15.63$15K - Jun 5, 2026NPCE
NeuroPace Inc
Award(A)Direct2.9K shares- - Mar 20, 2026NPCE
NeuroPace Inc
Award(A)Direct1.2K shares at avg. $13.00$15K - Dec 19, 2025NPCE
NeuroPace Inc
Award(A)Direct904 shares at avg. $16.59$15K - Sep 19, 2025NPCE
NeuroPace Inc
Award(A)Direct1.5K shares at avg. $9.94$15K - Jun 21, 2025NPCE
NeuroPace Inc
Award(A)Direct1.4K shares at avg. $10.41$15K - Jun 6, 2025NPCE
NeuroPace Inc
Award(A)DirectStock Option (right to buy)
8.7K shares- - Mar 21, 2025NPCE
NeuroPace Inc
Award(A)Direct1.2K shares at avg. $12.02$15K - Feb 20, 2025ROIV
Roivant Sciences Ltd.
Tax Payment(F)Direct958 shares at avg. $10.72$10K - Feb 13, 2025ROIV
Roivant Sciences Ltd.
Sale(S)Direct227.5K shares at avg. $10.43$2.4M - Feb 13, 2025ROIV
Roivant Sciences Ltd.
Exercise(M)Direct187.5K shares at avg. $3.85$722K - Jan 20, 2025ROIV
Roivant Sciences Ltd.
Tax Payment(F)Direct1.1K shares at avg. $11.15$12K - Dec 21, 2024NPCE
NeuroPace Inc
Award(A)Direct1.3K shares at avg. $11.53$15K - Dec 20, 2024ROIV
Roivant Sciences Ltd.
Tax Payment(F)Direct3.1K shares at avg. $11.57$36K - Nov 20, 2024ROIV
Roivant Sciences Ltd.
Tax Payment(F)Direct958 shares at avg. $11.49$11K - Oct 20, 2024ROIV
Roivant Sciences Ltd.
Tax Payment(F)Direct956 shares at avg. $11.92$11K - Sep 30, 2024NPCE
NeuroPace Inc
Award(A)Direct2.2K shares at avg. $6.97$15K - Sep 23, 2024ROIV
Roivant Sciences Ltd.
Exercise(M)Direct250K shares at avg. $3.85$963K - Sep 23, 2024ROIV
Roivant Sciences Ltd.
Sale(S)Direct250K shares at avg. $11.89$3.0M - Sep 20, 2024ROIV
Roivant Sciences Ltd.
Tax Payment(F)Direct3.1K shares at avg. $11.97$37K - Jun 28, 2024NPCE
NeuroPace Inc
Award(A)Direct2K shares at avg. $7.56$15K - Mar 29, 2024NPCE
NeuroPace Inc
Award(A)Direct1.1K shares at avg. $13.20$15K - Dec 29, 2023NPCE
NeuroPace Inc
Award(A)Direct1.5K shares at avg. $10.31$15K - Sep 29, 2023NPCE
NeuroPace Inc
Award(A)Direct1.5K shares at avg. $9.73$15K - Jun 30, 2023NPCE
NeuroPace Inc
Award(A)Direct3.3K shares at avg. $4.49$15K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 19, 2026 |  NPCE NeuroPace Inc | Award(A) | 989 | $15.63 | $15,458 | Direct |
| Jun 5, 2026 | NPCE NeuroPace Inc | Award(A) | 2,890 | - | $0 | Direct |
| Mar 20, 2026 | NPCE NeuroPace Inc | Award(A) | 1,153 | $13.00 | $14,989 | Direct |
| Dec 19, 2025 | NPCE NeuroPace Inc | Award(A) | 904 | $16.59 | $14,997 | Direct |
| Sep 19, 2025 | NPCE NeuroPace Inc | Award(A) | 1,509 | $9.94 | $14,999 | Direct |
| Jun 21, 2025 | NPCE NeuroPace Inc | Award(A) | 1,440 | $10.41 | $14,990 | Direct |
| Jun 6, 2025 | NPCE NeuroPace Inc | Award(A) Stock Option (right to buy) | 8,745 | - | - | Direct |
| Mar 21, 2025 | NPCE NeuroPace Inc | Award(A) | 1,247 | $12.02 | $14,989 | Direct |
| Feb 20, 2025 |  ROIV Roivant Sciences Ltd. | Tax Payment(F) | 958 | $10.72 | $10,270 | Direct |
| Feb 13, 2025 | ROIV Roivant Sciences Ltd. | Sale(S) | 227,500 | $10.43 | $2,372,825 | Direct |
| Feb 13, 2025 | ROIV Roivant Sciences Ltd. | Exercise(M) | 187,500 | $3.85 | $721,875 | Direct |
| Jan 20, 2025 | ROIV Roivant Sciences Ltd. | Tax Payment(F) | 1,057 | $11.15 | $11,786 | Direct |
| Dec 21, 2024 | NPCE NeuroPace Inc | Award(A) | 1,300 | $11.53 | $14,989 | Direct |
| Dec 20, 2024 | ROIV Roivant Sciences Ltd. | Tax Payment(F) | 3,087 | $11.57 | $35,717 | Direct |
| Nov 20, 2024 | ROIV Roivant Sciences Ltd. | Tax Payment(F) | 958 | $11.49 | $11,007 | Direct |
| Oct 20, 2024 | ROIV Roivant Sciences Ltd. | Tax Payment(F) | 956 | $11.92 | $11,396 | Direct |
| Sep 30, 2024 | NPCE NeuroPace Inc | Award(A) | 2,152 | $6.97 | $14,999 | Direct |
| Sep 23, 2024 | ROIV Roivant Sciences Ltd. | Exercise(M) | 250,000 | $3.85 | $962,500 | Direct |
| Sep 23, 2024 | ROIV Roivant Sciences Ltd. | Sale(S) | 250,000 | $11.89 | $2,972,500 | Direct |
| Sep 20, 2024 | ROIV Roivant Sciences Ltd. | Tax Payment(F) | 3,087 | $11.97 | $36,951 | Direct |
| Jun 28, 2024 | NPCE NeuroPace Inc | Award(A) | 1,984 | $7.56 | $14,999 | Direct |
| Mar 29, 2024 | NPCE NeuroPace Inc | Award(A) | 1,136 | $13.20 | $14,995 | Direct |
| Dec 29, 2023 | NPCE NeuroPace Inc | Award(A) | 1,454 | $10.31 | $14,991 | Direct |
| Sep 29, 2023 | NPCE NeuroPace Inc | Award(A) | 1,541 | $9.73 | $14,994 | Direct |
| Jun 30, 2023 | NPCE NeuroPace Inc | Award(A) | 3,340 | $4.49 | $14,997 | Direct |
1-25 of 25 transactions
About Kumar Rakhi
Kumar Rakhi (SEC CIK 0001856296) files insider reports with the SEC as Director of NeuroPace Inc (NPCE), Director of Amanat Acquisition Corp. (AMAN) and Chief Accounting Officer of Roivant Sciences Ltd. (ROIV).
Signal8 holds 15 ownership filings by Kumar Rakhi (1 Form 3, 14 Form 4), filed between Sep 24, 2024 and Jun 22, 2026. Those filings report 25 transactions, from Jun 30, 2023 to Jun 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kumar Rakhi's filings is in MOUNTAIN VIEW, CA.
Recent filings by Kumar Rakhi
- Jun 19, 2026: Grant or award of NPCE shares (Form 4, code A).
- Jun 5, 2026: Grant or award of NPCE shares (Form 4, code A).
- Mar 20, 2026: Grant or award of NPCE shares (Form 4, code A).
- Dec 19, 2025: Grant or award of NPCE shares (Form 4, code A).
- Sep 19, 2025: Grant or award of NPCE shares (Form 4, code A).
Other insiders filing for NeuroPace Inc (NPCE)
- Morrell Martha, CHIEF MEDICAL OFFICER
- Williams Patrick F., Chief Financial Officer
- Becker Joel, CHIEF EXECUTIVE OFFICER
- Geiger Uri, Director
- Fischer Frank M, Director
- Huennekens R Scott, Director